Canada markets closed

Pfizer Inc. (PFE)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
53.91-0.08 (-0.15%)
At close: 04:03PM EDT
53.87 -0.04 (-0.07%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close53.99
Open53.92
Bid53.87 x 1800
Ask53.98 x 4000
Day's Range53.51 - 54.40
52 Week Range38.48 - 61.71
Volume21,360,388
Avg. Volume27,271,677
Market Cap302.484B
Beta (5Y Monthly)0.71
PE Ratio (TTM)12.36
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield1.60 (2.97%)
Ex-Dividend DateMay 12, 2022
1y Target EstN/A
  • Reuters

    U.S. doctors reconsider Pfizer's Paxlovid for lower-risk COVID patients

    Use of Pfizer Inc's COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public health agency warned that symptoms can recur after people complete a course of the drug, and that they should then isolate a second time. More quarantine time "is not a crowd-pleaser," Dr. Sandra Kemmerly, an infectious disease specialist at Ochsner Health in New Orleans, told Reuters. Use of Pfizer's Paxlovid, authorized to treat newly infected, at-risk people in order to prevent severe illness, has soared as infections have risen.

  • Zacks

    Pfizer (PFE) Gets Fast Track Designation for NASH Therapy

    Pfizer (PFE) obtains Fast Track designation for its investigational combination therapy - ervogastat and clesacostat for the treatment of NASH.

  • Zacks

    Pharma Stock Roundup: EU Nod for AZN, JNJ & Others, PFE COVID Jab Effective in Kids

    European Commission authorizes a booster dose of AstraZeneca's (AZN) COVID-19 vaccine and approves Merck (MRK) and Roche's (RHHBY) oncology drugs for expanded use.